Top brokers name 3 ASX shares to sell next week

Top brokers have named Cochlear Limited (ASX:COH) and these ASX shares as the ones to sell next week…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were quite bearish.

Three sell ratings that caught my eye are summarised below. Here's why top brokers think investors ought to sell these shares next week:

a woman

Cochlear Limited (ASX: COH)

A note out of UBS reveals that it has retained its sell rating and $195.00 price target on this hearing solutions company's shares. According to the note, UBS feels current trends are unfavourable and doubts that Cochlear will be able to live up to the market's expectations over the medium term. The broker also points out that any benefit from the recent product recall by Advanced Bionics looks set to be limited due to the deferral of surgeries because of the coronavirus outbreak. Cochlear's share price finished the week at $205.00.

Magellan Financial Group Ltd (ASX: MFG)

Analysts at Goldman Sachs have retained their sell rating and $53.29 price target on this fund manager's shares. According to the note, the broker was a little disappointed with Magellan's performance in February. It notes that Magellan's High Conviction strategy underperformed by -4.6% during the month. And while its Global fund outperformed, it was expecting a stronger month given its emphasis on downside protection. In light of this, it appears to see no reason to change its rating at this point. Though, it is worth noting that its shares fell heavily on Friday and now trade below Goldman's price target at $52.90.

Reece Ltd (ASX: REH)

According to a note out of Citi, its analysts have retained their sell rating and $10.50 price target on this plumbing parts company's shares. This follows the release of its half year result last month, which was largely in line with the broker's expectations. However, Citi notes that this was due to a solid performance in the United States, which offset weakness in Australia. Unfortunately, it doesn't expect things to improve in the local market in the near term and fears this could lead to Reece falling short of expectations in the second half. The Reece share price finished the week at $11.30.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »